Comments
New Delhi, October 7 Drug firm Indoco Remedies on Monday said it has received approval from the US health regulator for Rasagiline tablets, used for the treatment of Parkinson’s disease.
The company has received the final nod for its abbreviated new drug application (ANDA) for Rasagiline tablets in the strengths of 0.5 mg and 1 mg from the United States Food and Drug Administration (USFDA), Indoco Remedies said in a regulatory filing.
Quoting IMS 2018 data, Indoco Remedies said the market size of this product in the US is USD 105 million.
“This is the first ANDA approval for Indoco after receipt of warning letter in March 2017 for Goa plant II and III. The company has 32 ANDAs pending for approval for different dosage forms from this site,” Indoco Remedies Managing Director Aditi Kare Panandikar said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.